Aug 3, 2026 08:04AM
Aug 3, 2026 06:35AM
Aug 3, 2026 06:31AM
Aug 3, 2026 06:30AM
May 5, 2026 04:05PM
Feb 24, 2026 04:05PM
Feb 17, 2026 08:30AM Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
Dec 19, 2025 07:48AM
Dec 9, 2025 07:00AM
Nov 4, 2025 04:01PM
Oct 21, 2025 05:00PM
Sep 17, 2025 04:30PM
Sep 17, 2025 04:30PM
Aug 27, 2025 04:15PM Supernus Pharmaceuticals to Participate in September Investor Conferences
Aug 6, 2025 10:26AM
Aug 5, 2025 04:05PM
Jul 31, 2025 08:44AM
Jul 31, 2025 08:44AM
Jul 28, 2025 08:25AM
Jul 28, 2025 08:25AM
Jul 22, 2025 04:30PM Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025
Jun 16, 2025 07:01AM
Jun 16, 2025 07:00AM
Aug 21, 2023 09:01AM
Aug 21, 2023 09:00AM
Feb 28, 2023 04:05PM
Feb 28, 2023 04:05PM
Nov 8, 2022 04:05PM Supernus Announces Third Quarter 2022 Financial Results
Nov 8, 2022 04:05PM
Aug 4, 2022 04:01PM
Aug 4, 2022 04:01PM
May 9, 2022 04:05PM
May 9, 2022 04:05PM
Apr 13, 2022 04:11PM
Apr 13, 2022 04:11PM Supernus Reports Final Audited Fourth Quarter and Full Year 2021 Financial Results
Feb 28, 2022 04:05PM
Feb 28, 2022 04:05PM
Nov 24, 2021 09:12AM
Nov 24, 2021 09:12AM
Nov 23, 2021 08:01AM
Nov 23, 2021 08:00AM
Nov 23, 2021 08:00AM Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals Tender Offer
Nov 3, 2021 04:01PM
Nov 3, 2021 04:01PM
Oct 27, 2021 12:36PM
Oct 14, 2021 03:32PM
Oct 11, 2021 09:21AM
Oct 11, 2021 06:30AM
Oct 11, 2021 06:30AM Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio
Oct 11, 2021 06:30AM

1,177,378 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All